A Look at the Portfolio of the California Stem Cell Agency

Look at the status of CIRM funding by disease

LOS ANGELES -- The California stem cell agency this morning presented a fresh breakdown of its spending by disease areas. The largest two components are in the neuro and cancer areas, which account for nearly half of the agency's portfolio.